• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Obesity – The Worldwide Market for Pharmaceutical and Surgical Treatment

$995.00 – $7,000.00

Clear
SKU: KLI1190852 Category: Pharmaceuticals Market Research Pages: 160
  • Description
  • Table of Contents
  • Latest reports

Description

Despite troublesome safety problems with past entrants into this market, the veritable epidemic of overweight and obesity continues to make this sector an extremely attractive target for pharmaceutical developers. This new title provides a considered view of the market for medical interventions in the battle against obesity, including U.S. and worldwide market size and growth forecasts, competitive market share and extensive pharmaceutical pipeline information.

The report discusses both prescription and OTC drug markets and surgical interventions. Market size and growth rates are provided through 2010 for:

  • Prescription Appetite Suppressants
  • Prescription Lipase Inhibitors
  • OTC Appetite Suppressants
  • OTC Fat Substitutes
  • Surgical Intervetion (dollar- and procedure volumes)

Complete epidemilogical data, detailed descriptions of over 50 compounds in development for this sector, and profiles of 14 top suppliers are provided as well.

Table of Contents

Chapter One: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Chapter Two: Introduction

  • Overview of Obesity and Weight Management
    • Definition of Overweight and Obesity
    • Homeostatic Mechanisms Controlling Energy Balance
      • Linking Energy Stores in Body Fat with the Hypothalamus
      • Insulin as the Sensor of Energy Stores in Fat
      • Integration and Effect on Energy Balance
    • Regulation of Energy Expenditure and Food Intake
      • Energy Expenditure
      • Food Intake
    • Pathophysiology of Obesity
      • Obesity Disorder of the Homeostatic Control of Energy Balance
      • Genetic Factors
      • Food Intake
      • Physical Exercise
    • Causes of Overweight and Obesity
      • Genetics
      • Environmental
      • Socioeconomic
    • Health Risks
    • Economic Consequences
  • Demographics
  • Obesity Management

Chapter Three: Issues and Trends

  • Over-the Counter Xenical
  • Cortisol and Obesity
  • Weight and Height Trends
  • Educational Efforts of Physical Activity
    • Sedentary Behavior in Overweight and Obese Persons
    • Role of Physical Activity in Body Weight Regulation
    • Educating Patients About the Benefits of Activity
      • Cardiovascular and All-Cause Mortality
      • Cardiovascular Risk Factors
      • Fat and Muscle During Weight Loss
      • Physical and Psychologic Well-being
      • Long-term Weight Maintenance
  • Fat Gene Mapping Tool
  • Laser Melts Fat
  • Ciliary Neurotrophic Factor Update
  • Drinking and Obesity
  • Exercise Gene
  • Trends in Childhood Obesity
  • Effect of Modernization on Obesity
  • Insurance Coverage Issues
    • Medicare
    • Medicaid
    • Medicare Coverage of Bariatric Surgery
  • Selected Weight Loss Programs

Chapter Four: Prescription Pharmaceutical Market

  • Description of Products
    • Appetite Suppressants
    • Sympathomimetic Amine
    • Monoamine Reuptake Inhibitor
    • Lipase Inhibitors
  • Market Size and Growth
    • World Market
    • World Market and U.S. Market Analysis
    • Competitive Analysis

Chapter Five: Over-the-Counter Drugs

  • Overview
  • Description of Products
    • Appetite Suppressants
    • Noradrenergic Agents
    • Caffeine-based Agents
    • Benzocaine-Based Agents
    • Fat Substitutes
    • Others
    • 5HTP-Trptophan
    • Hoodia
  • Market Size and Growth
    • World Market
    • World Market and U.S. Market Analysis
    • Competitive Analysis

Chapter Six: Surgical Interventions

  • Overview
  • Description of Products
    • Restrictive Surgery
    • Combined Restrictive and Malabsorptive Surgery
  • Market Size and Growth
    • World Market
    • World Market and U.S. Market Analysis
    • Procedure Volumes

Chapter Seven: Pharmaceutical Research and Development

  • Overview
  • Description of Products
    • 5HT2-C Agonists
    • APD 356
    • WAY 629 & WAY 909
    • 5HT-6 Antagonists (BVT.5182)
    • Adiponectin (ACRP30 [Famoxin])
    • Amylin Analogs (Symlin [AC137])
    • Angiogenesis Inhibitors (TNP-470)
    • B-3AR Agonists
    • Botanical P57
    • Calpain-3
    • Cannabinoid-1 Receptor antagonists
    • Acomplia
    • L-000899055
    • SLV319
    • SR 147778
    • CCK-A Agonists
    • Cholesterol Metabolites (MSI-1436)
    • Cholesterol Transport Inhibitors (FM-VP4)
    • Ciliary Neurotrophic Factor (CNTF) (Axokine)
    • Extendin-4 (AC3174)
    • Fatty Acid Synthase Inhibitor (C75)
    • Fibroblast Growth Factor-1 Inhibitor
    • FIT Gene and Ion Channel (CSX121, CSX 102 and CXS-829)
    • Ghrelin Antagonist
    • Histamine-3 Antagonists
    • A-331440
    • NNC 0038-0000-1202
    • Human Growth Hormone Fragments (AOD 9604)
    • Leptin Agonists (CBT 1452)
    • Lipase Inhibitors
    • ATL 962
    • GT389-255
    • Melanin Concentrating Hormone-1 Receptor Antagonists
    • A-798
    • GW803430
    • NGX-1
    • SNAP 7941 SNAP94847
    • Melanocortin-4 Receptor Agonists
    • BIM-22103
    • NNC 70-619
    • Microsomal Triglyceride Transfer Protein (MTP) Inhibitor (SLx-4090)
    • Neuropeptide y2 Receptor Antagonist
    • Neuropeptide Y Agonist (TM30338 and TM30339)
    • Neuropeptide Y5 Receptor Antagonist (S-2367)
    • Nicotine Receptor Ligand (TC-2216/TC-2286)
    • Obestatin
    • Oleoyl-estrone
    • Oleoylethanolamide
    • Osmotin
    • Oxyntomodulin
    • Peroxisome Proliferator Activated Receptor (GW501516)
    • Peroxisome Proliferator Activated Receptor-Pan Agonist (DRL 11605)
    • Gut Hormone Peptide (PYY)
    • PPY3-36
    • AC 162352
    • Retinoid X Receptor: Peroxisome Proliferator Activated
    • Receptor Agonists (LG100268)
    • RIP140 Inhibitor
    • Selective Androgen Receptor Modulator (SARM) (Ostarine)
    • Stearoyl-COA Desaturase-1
    • Thyroid Hormone-B Receptor Agonist (KB-2115)
    • Vaccines (CYT009)
    • Others
    • BDC-03
    • BL-2040
    • HMR 1426
    • Orexin

Chapter Eight: World Market Summary

  • Overview
  • Total market Size and Forecast
  • Competitor Analysis

Chapter Nine: Corporate Profiles

  • Abbott Laboratories
  • Alizyme
  • Arena Pharmaceuticals
  • ChemGenex Pharmaceuticals
  • GlaxoSmithKline plc
  • Ligand Pharmaceuticals, Inc
  • Manhattan Pharmaceuticals, Inc
  • Merck & Company, Inc.
  • Metabolic Pharmaceuticals Limited
  • Novartis
  • Proctor & Gamble
  • Regeneron Pharmaceuticals Inc
  • Roche Group
  • Sanofi-Aventis

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: Market Summary: The World Market for Obesity Treatments 2000-2010
  • Figure 1-1: Market Summary: Trending in the World Market for Obesity Treatments by Segment 2000-2010
  • Table 1-2: Revenues and Segments of Participation by Leading Market Participants (Prescription and OTC Markets) 2005

Chapter Two: Introduction

  • Table 2-1: Body Mass Index (BMI) Chart
  • Table 2-2: Causes of Overweight and Obesity
  • Table 2-3: Percent Distributions of BMI Among Persons Age 18 and Over by Weight Characteristic (Underweight, Healthy Weight, Overweight, Obese) and Selected Demographic Characteristics (Age Group, Sex) 2003

Chapter Three: Issues and Trends

  • Table 3-1: Prevalence of Obesity in Children and Adolescents 1976-2004
  • Table 3-2: Impact of Modernization on Obesity
  • Table 3-3: Medicaid Insurance Coverage by State (Xenical, Meridia, Phentermine) and Prior Authorization Requirments
  • Table 3-4: Popular Weight Loss Programs

Chapter Four: Prescription Pharmaceutical Market

  • Table 4-1: Prescription Appetite Suppressant Medications
  • Table 4-2: The World Market for Prescription Anti-obesity and Weight Loss Drugs by Type (Appetite Suppressants, Lipase Inhibitors) 2000-2010
  • Figure 4-1: Trending in the World Market for Prescription Anti-obesity and Weight Loss Drugs 2000-2010
  • Table 4-3: The Market for Prescription Anti-Obesity and Weight Loss Drugs (U.S. vs World Revenues) 2000-2010
  • Table4-4: The World Market for Prescription Anti-obesity and Weight Loss Drugs, Revenues and Market Share by Supplier 2005
  • Figure 4-2: The World Market for Prescription Anti-Obesity and Weight Loss Drugs, Market Share by Leading Supplier 2005

Chapter Five: Over-the-Counter Drugs

  • Table 5-1: The World Market for Over-the-Counter Anti-obesity and Weight Loss Drugs by Type (Appetite Suppressants, Fat Substitutes) 2000-2010
  • Figure 5-1: Trending in the World Market for Over-the-Counter Anti-Obesity and Weight Loss Drugs 2000-2010
  • Table 5-2: The Market for Over-the-Counter Anti-Obesity and Weight Loss Drugs (U.S. vs World Revenues) 2000-2010

Chapter Six: Surgical Interventions

  • Table 6-1: The World Market for Obesity Surgical Interventions 2000-2010
  • Figure 6-1: Trending in the World Market for Obesity Surgical Interventions 2000-2010
  • Table 6-2: The Market for Obesity Surgical Interventions (U.S. vs World Revenues) 2000-2010
  • Table 6-3: Number of Bariatric Procedures 2000-2005

Chapter Seven: Pharmaceutical Research and Development

  • Table 7-1: Anti-Obesity Pharmaceuticals in Research and Development

Chapter Eight: World Market Summary

  • Table 8-1: The World Market for Obesity Treatments Revenues by Segment 2000-2010
  • Figure 8-1: Trending in the World Market for Obesity Treatments by Segment 2000-2010
  • Table 8-2: Revenues and Segments of Participation by Leading Market Participants (Prescription and OTC Markets) 2005

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    Market for Generic Biologics: Issues, Trends, and Market Potential, The

    $1,500.00 – $3,000.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Outsourcing in Drug Development: The Contract Research (CRO) Market, 2nd Ed...Advances in Ophthalmology – Markets in the Treatment of Eye Disorders...
Scroll to top